Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California.

Ho, Gwendolyn; Wun, Ted; Muffly, Lori; Li, Qian; Brunson, Ann; Rosenberg, Aaron S; Jonas, Brian A; Keegan, Theresa H M

Ho, Gwendolyn; Wun, Ted; Muffly, Lori; Li, Qian; Brunson, Ann; Rosenberg, Aaron S; Jonas, Brian A; Keegan, Theresa H M.

Afiliação

Ho G; Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, Department of Internal Medicine, University of California at Davis School of Medicine, Sacramento, California.
Wun T; Department of Hematology Oncology, Kaiser Permanente North Valley, Sacramento, California.
Muffly L; Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, Department of Internal Medicine, University of California at Davis School of Medicine, Sacramento, California.
Li Q; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, California.
Brunson A; Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, Department of Internal Medicine, University of California at Davis School of Medicine, Sacramento, California.
Rosenberg AS; Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, Department of Internal Medicine, University of California at Davis School of Medicine, Sacramento, California.
Jonas BA; Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, Department of Internal Medicine, University of California at Davis School of Medicine, Sacramento, California.
Keegan THM; Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, Department of Internal Medicine, University of California at Davis School of Medicine, Sacramento, California.

Cancer ; 124(9): 1938-1945, 2018 05 01.

Article em En | MEDLINE | ID: mdl-29451695

Assuntos

Antineoplásicos/efeitos adversos; Institutos de Câncer/estatística & dados numéricos; Parada Cardíaca/mortalidade; Leucemia Mieloide Aguda/mortalidade; Insuficiência Renal/mortalidade; Insuficiência Respiratória/mortalidade; Adulto; Idoso; Antineoplásicos/administração & dosagem; California/epidemiologia; Feminino; Parada Cardíaca/etiologia; Humanos; Leucemia Mieloide Aguda/complicações; Leucemia Mieloide Aguda/terapia; Masculino; Pessoa de Meia-Idade; National Cancer Institute (U.S.)/estatística & dados numéricos; Sistema de Registros/estatística & dados numéricos; Indução de Remissão/métodos; Insuficiência Renal/etiologia; Insuficiência Respiratória/etiologia; Classe Social; Análise de Sobrevida; Fatores de Tempo; Resultado do Tratamento; Estados Unidos; United States Department of Veterans Affairs/estatística & dados numéricos; Adulto Jovem

Palavras-chave

acute myeloid leukemia (AML); complications; early mortality; epidemiology; health services; location of care

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Respiratória / Institutos de Câncer / Leucemia Mieloide Aguda / Insuficiência Renal / Parada Cardíaca / Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google